These newer agents appear to be effective in the treatment of bipolar disorder, especially for those patients with rapid cycling, dysphoric or mixed mania, or neurologic abnormalities.
The Bipolar Disorder Biobank contains information and blood samples from more than 2,500 people with bipolar type 1 or 2 disorder. It is a valuable resource for research to better understand bipolar ...
AbbVie will buy Aliada Therapeutics for $1.4 billion in cash, it said on Monday, gaining access to the privately held therapy developer's Alzheimer's disease candidate as the U.S. drugmaker increases ...
Treatment methods will depend on the cause of the hallucinations and can range ... Psychosis in bipolar disorder: Does it represent a more 'severe' illness?. Bipolar Disord. 2018;20(1):18-26.